The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection is a research paper published in JACC Basic to Translational Science (2020). On theSindex it has a DataRank of 0. It has been cited 88 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Tulane University
Grant: ATN-161
U.S. Department of Defense
Grant: W8IXWH1910926
NIH HHS
Grant: P51 OD011104
National Institutes of Health
Grant: 5R21AI126361-02
Multiplexed quantification of circulating peptidomic signatures for EBOLA early diagnosis
National Institutes of Health
Grant: 5R01AI113725-04
Real-time Detection of Active TB in HIV Exposed Children on CustomizedNanotrap
National Institutes of Health
Grant: 1R35HL139930-01
CD4_T-cell_Immunity_in_the_Lung
National Institutes of Health
Grant: 5R21EB026347-02
Mobile based Nanoplasmonic Quantification of Mtb-derived Exosomes in Serum for Pediatric TB diagnosis
National Institutes of Health
Grant: 7R01HD090927-04
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
National Institutes of Health
Grant: 5R01AI122932-03
Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring
National Center for Research Resources
National Institutes of Health
U.S. Department of Defense
FWCI
1.90
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals